Search clinical trials for: CVVH with Biphozyl® in the second 48h after randomization (after previous 48h with Phoxilium®)

Total 2 results

Medical University Innsbruck

Completed

Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

Acute Kidney Injury | Critically Ill | Renal Replacement Therapy | Continuous Renal Replacement Therapy | Continuous Veno-Venous Hemofiltration | Replacement Fluid | Phoxilium | Biphozyl | Anticoagulation | Regional Citrate Anticoagulation

Austria
Memorial Sloan Kettering Cancer Center
Pfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of Virginia

Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Neurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial Hemangiopericytoma

United States

3

Subscribe